NCT07024277Not yet recruitingPhase 2
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
A Phase II Study Evaluating the Preliminary Efficacy and Safety of ZG006 in Participants With Metastatic Neuroendocrine Prostate Cancer
Source: ClinicalTrials.gov · Last updated 17 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a multicenter, open-label Phase II study, aimed at exploring the preliminary efficacy and safety of ZG006 in patients with advanced metastatic NEPC who have previously failed standard treatment.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 9 Jun 2025
- Start date
- Aug 2025
- Primary completion date
- Dec 2027
- Lead sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Diseases
- Prostate cancer
- NCT number
- NCT07024277
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 60
- From Aug 2025 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known positive test for human immunodeficiency virus (HIV) or hepatitis；
Other
- Patients were deemed unsuitable for participating in the study by the investigator for any reason.
Who the study is looking for
- Male Participants aged 18 to 80 years (inclusive);
- Advanced metastatic neuroendocrine prostate cancer;
- disease progression after at least one line of platinum-based systemic therapy or intolerance to toxicity;
- Measurable disease according to RECIST v1.1 criteria;
- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.
Age in the registry: 18 years to 80 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.